Correlation Between Akero Therapeutics and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and ZyVersa Therapeutics, you can compare the effects of market volatilities on Akero Therapeutics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and ZyVersa Therapeutics.
Diversification Opportunities for Akero Therapeutics and ZyVersa Therapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Akero and ZyVersa is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Akero Therapeutics and ZyVersa Therapeutics
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.42 times more return on investment than ZyVersa Therapeutics. However, Akero Therapeutics is 2.41 times less risky than ZyVersa Therapeutics. It trades about 0.08 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 1,766 in Akero Therapeutics on August 27, 2024 and sell it today you would earn a total of 1,507 from holding Akero Therapeutics or generate 85.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Akero Therapeutics |
| ZyVersa Therapeutics |
Akero Therapeutics and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and ZyVersa Therapeutics
The main advantage of trading using opposite Akero Therapeutics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |